
1. intern med. 2015;54(6):657-61. doi: 10.2169/internalmedicine.54.2332. epub 2015
jan 15.

late onset post-transfusion hepatitis e developing chemotherapy acute 
promyelocytic leukemia.

fuse k(1), matsuyama y, moriyama m, miyakoshi s, shibasaki y, takizawa j,
furukawa t, fuse i, matsumura h, uchida s, takahashi y, kamimura k, abe h, suda
t, aoyagi y, sone h, masuko m.

author information: 
(1)department hematology, endocrinology metabolism niigata university
faculty medicine, japan.

we herein report case leukemia patient developed hepatitis e seven
months undergoing transfusion contaminated blood products. the
latency period case significantly longer typical
hepatitis e. recently, chronic infection hepatitis e virus (hev) genotype 3 
has reported immunocompromised patients. possibility 
patient unable eliminate virus due immunosuppression following
chemotherapy administration steroids. prevalence hev healthy
japanese individuals relatively high constitutes critical source of
infection via transfusion. hepatitis e important post-transfusion
infection, immunocompromised patients may exhibit long latency period
before developing disease.

doi: 10.2169/internalmedicine.54.2332 
pmid: 25786459  [indexed medline]

